AML patients (n = 60) | Control (n = 30) | Test of Sig | p | |
---|---|---|---|---|
Gender | ||||
Male | 24 (40%) | 6 (20%) | χ2 = 3.600 | 0.058 |
Female | 36 (60%) | 24 (80%) | ||
Age (years) | t = 1.022 | 0.309 | ||
Mean ± SD | 38.5 ± 10.5 | 36.07 ± 10.17 | ||
Hb (g/dl) | t = 17.480* | < 0.001* | ||
Mean ± SD | 7.88 ± 1.06 | 12.15 ± 1.15 | ||
WBCs (109/L) | ||||
Median (Min. – Max.) | 32 (1.62 – 116.7) | 4.80 (3.9 – 6.5) | U = 57.500* | < 0.001* |
Platelets (109/L) | ||||
Mean ± SD | 49.67 ± 16.78 | 254.5 ± 43.12 | t = 25.088* | < 0.001* |
BM blasts at diagnosis (%) | ||||
Mean ± SD | 72.82 ± 17.07 | |||
Median (Min. – Max.) | 78.0 (28.0 – 97.0) | |||
2–ΔΔCT DANCR | ||||
Median (Min.-Max.) | 0.64 (0.07–6.09) | 1.02 (0.20–5.68) | U = 657.50* | 0.038* |